Effect of Glucocorticoid Use in Patients With Biopsy-Proven Acute Interstitial Nephritis: Insights From a Colombian Cohort
Conclusion: GC therapy may improve kidney outcomes in patients with biopsy-proven AIN, especially when initiated early. These results support the need for prospective studies to further evaluate its efficacy in AIN management.
Saved in:
| Main Authors: | Joaquín Rodelo-Ceballos, Camilo García-Prada, Mauricio Restrepo-Escobar, Laura Lopera-Restrepo, Angie Pinto-Diaz, Luis Fernando Arias-Restrepo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | International Journal of Nephrology |
| Online Access: | http://dx.doi.org/10.1155/ijne/9980649 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radiologic evolution of biopsy-proven acute interstitial nephritis: a multimodal imaging case report
by: Euljo Jeong, et al.
Published: (2025-03-01) -
Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
by: Bancha Satirapoj, et al.
Published: (2015-01-01) -
Prognostic Utility of the MEST-C Score Combined With Clinical Parameters in Hispanic Patients With IgA Nephropathy
by: Lyzinhawer Alza-Arcila, et al.
Published: (2025-01-01) -
Clinicopathological Characteristics and Kidney Outcomes in Biopsy-Confirmed Acute Interstitial Nephritis
by: Jing Miao, et al.
Published: (2024-12-01) -
WCN25-2590 Long-term outcomes and role of steroids in biopsy-proven Acute Interstitial Nephritis: A single center experience of 10 years from India
by: Harshita Sharma, et al.
Published: (2025-02-01)